1. Home
  2. CNTA vs SEMR Comparison

CNTA vs SEMR Comparison

Compare CNTA & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • SEMR
  • Stock Information
  • Founded
  • CNTA 2020
  • SEMR 2008
  • Country
  • CNTA United Kingdom
  • SEMR United States
  • Employees
  • CNTA N/A
  • SEMR N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • SEMR EDP Services
  • Sector
  • CNTA Health Care
  • SEMR Technology
  • Exchange
  • CNTA Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • CNTA 2.2B
  • SEMR 2.6B
  • IPO Year
  • CNTA 2021
  • SEMR 2021
  • Fundamental
  • Price
  • CNTA $14.59
  • SEMR $9.57
  • Analyst Decision
  • CNTA Strong Buy
  • SEMR Buy
  • Analyst Count
  • CNTA 8
  • SEMR 7
  • Target Price
  • CNTA $23.86
  • SEMR $18.14
  • AVG Volume (30 Days)
  • CNTA 1.1M
  • SEMR 819.8K
  • Earning Date
  • CNTA 03-24-2025
  • SEMR 05-05-2025
  • Dividend Yield
  • CNTA N/A
  • SEMR N/A
  • EPS Growth
  • CNTA N/A
  • SEMR 747.54
  • EPS
  • CNTA N/A
  • SEMR 0.06
  • Revenue
  • CNTA N/A
  • SEMR $376,815,000.00
  • Revenue This Year
  • CNTA N/A
  • SEMR $22.30
  • Revenue Next Year
  • CNTA N/A
  • SEMR $19.65
  • P/E Ratio
  • CNTA N/A
  • SEMR $169.93
  • Revenue Growth
  • CNTA N/A
  • SEMR 22.47
  • 52 Week Low
  • CNTA $7.75
  • SEMR $9.21
  • 52 Week High
  • CNTA $19.09
  • SEMR $18.74
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 38.85
  • SEMR 31.01
  • Support Level
  • CNTA $13.78
  • SEMR $9.74
  • Resistance Level
  • CNTA $16.87
  • SEMR $10.09
  • Average True Range (ATR)
  • CNTA 1.07
  • SEMR 0.40
  • MACD
  • CNTA -0.23
  • SEMR 0.19
  • Stochastic Oscillator
  • CNTA 19.33
  • SEMR 29.03

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

Share on Social Networks: